Crossmark

Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database

Published Online: 2022-04-28

Published Print: 2022-06

Authors

Mease, Philip J.

Young, Pamela

Gruben, David

Fallon, Lara

Germino, Rebecca

Kavanaugh, Arthur
Funding

Funding for this research was provided by:

Pfizer Inc
License Information

Text and Data Mining valid from 2022-04-28

Version of Record valid from 2022-04-28
More Information

Article History

Received: 29 November 2021

Accepted: 10 February 2022

First Online: 28 April 2022

Document is current